(Q46299846)

English

Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18948425

Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18948425

0 references

randomized controlled trial

1 reference

based on heuristic

inferred from title

David W. Denning

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18948425

Graham Atherton

object named as

Graham T Atherton

5

0 references

object named as

Robert M Niven

9

0 references

author name string

B Ronan O'Driscoll

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18948425

Georgina Powell

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18948425

Fiona Chew

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18948425

Aashish Vyas

6

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18948425

John Miles

7

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18948425

Julie Morris

8

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18948425

language of work or name

0 references

publication date

23 October 2008

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18948425

American Journal of Respiratory and Critical Care Medicine

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18948425

179

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18948425

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18948425

11-18

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18948425

The link between fungi and severe asthma: a summary of the evidence.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200805-737OC

21 January 2018

Adjunctive Therapy of Allergic Bronchopulmonary Aspergillosis with Itraconazole

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200805-737OC

21 January 2018

A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200805-737OC

21 January 2018

Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200805-737OC

21 January 2018

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200805-737OC

21 January 2018

Bioassay for serum itraconazole concentrations using hydroxyitraconazole standards

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200805-737OC

21 January 2018

Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200805-737OC

21 January 2018

Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200805-737OC

21 January 2018

Mold sensitization is common amongst patients with severe asthma requiring multiple hospital admissions

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200805-737OC

21 January 2018

Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200805-737OC

21 January 2018

Efficacy of omalizumab, an anti-immunoglobulin E antibody, in patients with allergic asthma at high risk of serious asthma-related morbidity and mortality.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200805-737OC

21 January 2018

Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200805-737OC

21 January 2018

Immunoglobulin E-binding and skin test reactivity to hydrophobin HCh-1 from Cladosporium herbarum, the first allergenic cell wall component of fungi

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200805-737OC

21 January 2018

Airborne fungal fragments and allergenicity

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200805-737OC

21 January 2018

Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200805-737OC

21 January 2018

Profound adrenal suppression secondary to treatment with low dose inhaled steroids and itraconazole in allergic bronchopulmonary aspergillosis in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200805-737OC

21 January 2018

Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200805-737OC

21 January 2018

Anti-mycotics suppress interleukin-4 and interleukin-5 production in anti-CD3 plus anti-CD28-stimulated T cells from patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200805-737OC

21 January 2018

Expression of immunomodulatory genes in human monocytes induced by voriconazole in the presence of Aspergillus fumigatus

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200805-737OC

21 January 2018

Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200805-737OC

21 January 2018

Itraconazole suppresses an elicitation phase of a contact hypersensitivity reaction

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200805-737OC

21 January 2018

Evaluating the Response of Patients Undergoing Both Allergy Skin Testing and in Vitro Allergy Testing With the ImmunoCAP Technology System

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200805-737OC

21 January 2018

Identifiers

10.1164/RCCM.200805-737OC

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18948425

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18948425

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46299846&oldid=2104074300"